← Open Payments lookup

MIKAYLA BALLARD: Open Payments

NPI 1770358780 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,352 in 59 payments from 16 companies in 2025. Trend: 2023 $120 · 2024 $830 · 2025 $1,352

Food & beverage: $1,352
CompanyPaymentsAmount
Gilead Sciences, Inc.15$471
ViiV Healthcare Company10$142
Neurocrine BioSciences, Inc.5$115
ABBVIE INC.5$107
Vanda Pharmaceuticals Inc.5$103
Otsuka America Pharmaceutical, Inc.4$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
EMD Serono, Inc.2$62
Alkermes, Inc.3$52
Indivior Inc.1$32

Products named: Biktarvy, DOVATO, INGREZZA, Yeztugo, VRAYLAR, CAPLYTA, REXULTI, FANAPT.

Industry payments across AR — which companies pay providers there.